duct cell adenocarcinoma of the pancreas
Showing 1 - 22 of 22
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +5 more
-
Fairfield, Connecticut
- +8 more
Oct 31, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Suspended
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +4 more
-
Detroit, Michigan
- +1 more
Feb 2, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- +4 more
-
Cleveland, Ohio
- +1 more
Aug 9, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- paclitaxel
- bryostatin 1
-
Bronx, New YorkMontefiore Medical Center
May 18, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- stereotactic radiosurgery
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Jun 24, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (biological,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +3 more
- ipilimumab
- +2 more
-
Chicago, IllinoisNorthwestern University
Feb 24, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Terminated
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- bortezomib
- +2 more
-
Houston, TexasMD Anderson Cancer Network
Oct 30, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IIB Pancreatic Cancer Trial in
Terminated
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- gemcitabine hydrochloride
- +4 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 26, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- vismodegib
- +6 more
-
Scottsdale, Arizona
- +2 more
Apr 4, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- 6,8-bis(benzylthio)octanoic acid
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 26, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- porfimer sodium
- +3 more
-
Indianapolis, IndianaIU Simon Cancer Center
Dec 11, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +7 more
-
La Jolla, California
- +13 more
Aug 30, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +7 more
- dasatinib
- +5 more
-
Alhambra, California
- +16 more
Jan 5, 2018
Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (drug,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +3 more
-
Rochester, MinnesotaMayo Clinic
Mar 21, 2017
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Buffalo (dovitinib
Withdrawn
- Duct Cell Adenocarcinoma of the Pancreas
- +4 more
- dovitinib lactate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 8, 2015
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Liver Metastases Trial in Duarte
Withdrawn
- Acinar Cell Adenocarcinoma of the Pancreas
- +7 more
- dynamic contrast-enhanced magnetic resonance imaging
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 28, 2014
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2013
Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in Rochester (bortezomib, gemcitabine HCl)
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- Stage IV Pancreatic Cancer
- bortezomib
- gemcitabine hydrochloride
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Oct 7, 2013
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- sunitinib malate
-
Chicago, Illinois
- +1 more
Jun 3, 2013